Legal & General Group PLC Imara Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.78 - $9.04 $6,617 - $8,823	-976 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.18 - $23.98 $981 - $2,877	120 Added 14.02%	976 $8,000
Q4 2020 Feb 12, 2021	BUY	$15.81 - $29.0 $3,683 - $6,757	233 Added 37.4%	856 $19,000
Q3 2020 Nov 13, 2020	SELL	$18.75 - $28.58 $3,618 - $5,515	-193 Reduced 23.65%	623 $13,000
Q2 2020 Aug 14, 2020	BUY	$15.6 - $54.87 $12,729 - $44,773	816 New	816 $22,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.